The fluorodeoxyglucose (FOG) method for the measurement of local cerebral metabolic rate of glucose (LCMRGIc) employs typical values of the FOG transport rate constants that have been obtained by kinetic mea surements on an appropriate control group. Discrepancies between the true values of the rate constants in tissue and the typical values used in the opera tional equation of the FOG method will introduce error in the estimate of LCMRGIc. Computer simulations were used to evaluate the accuracy of the FOG method in cases where (1) the tissue LCMRGIc deviates greatly from the normal values (e.g., stroke) or (2) the tissue LCMRGIc changes during the experiment (e.g., epileptic seizure). The effects of the magnitude and duration of metabolic changes were studied. The rsults indicate that if tissue LCMRGIc differs greatly from the normal value, the error in the estimated LCMRGIc at a scan time of 60 min is less than 20% of the difference between the true and normal values. In the non-steady-state cases, the estimated LCMRGIc was found to be a weighted average of the metabolic rates during the experiments, with the weightings approximately proportional to the plasma FOG concentra tion at the corresponding times. 
Summary:
The fluorodeoxyglucose (FOG) method for the measurement of local cerebral metabolic rate of glucose (LCMRGIc) employs typical values of the FOG transport rate constants that have been obtained by kinetic mea surements on an appropriate control group. Discrepancies between the true values of the rate constants in tissue and the typical values used in the opera tional equation of the FOG method will introduce error in the estimate of LCMRGIc. Computer simulations were used to evaluate the accuracy of the FOG method in cases where (1) the tissue LCMRGIc deviates greatly from the normal values (e.g., stroke) or (2) the tissue LCMRGIc changes during the experiment (e.g., epileptic seizure). The effects of the magnitude and duration of metabolic changes were studied. The rsults indicate that if tissue LCMRGIc differs greatly from the normal value, the error in the estimated LCMRGIc at a scan time of 60 min is less than 20% of the difference between the true and normal values. In the non-steady-state cases, the estimated LCMRGIc was found to be a weighted average of the metabolic rates during the experiments, with the weightings approximately proportional to the plasma FOG concentra tion at the corresponding times. For example, if LCMRGIc in tissue was 5 times the normal values for the first 10 min but then returned to normal state, the LCMRGIc measured by the FOG method at a scan time of 60 min would be about only 2-3 times the normal value. The results of this study provide a better understanding of the accuracy of the FOG method under various tissue metabolic conditions and is useful for interpreting metabolic values obtained with the FOG method. Key Words: Fluorodeoxyglucose-Local cerebral met abolic rate of glucose-Error sensitivity-Non-steady-state conditions Computer simulation. (Reivich et aI., 1979; Phelps et aI., 1979; Huang et aI., 1980) for the measurement of local cerebral metabolic rate of glucose (LCMRGlc) in man is based on the characteristics of FDG as a glucose analog that is trapped in cerebral tissue (Bidder, 1968; Bachelard, 1971; Bessel et aI., 1972; Gallagher et aI., 1978) and on a deoxyglucose transport model originally developed by Sokoloff et ai. (1977) and later extended in this laboratory (Phelps et aI., 1979; Huang et aI., 1980) . The method requires (a) an in travenous (i.v.) injection of an FDG bolus in a sub ject, (b) a series of blood samples withdrawn from the subject to determine the plasma glucose con centration and the time function of FDG concentra tion in plasma, and (c) tomographic measurements of the local cerebral tissue 18F concentration by positron emission computed tomography (PCT) at times between 40 and 120 min after FDG injection. These measurements are then used in an opera tional equation that requires a set of typical values of FDG transport rate constants! to calculate LCMRGlc in various regions of the brain. In the application of the FOG method, there are many sources of error that can affect the accuracy of the estimated LCMRGlc values, as have been dis cussed previously (Huang et aI., 1980) . The effects of most of these sources of error on LCMRGlc ac curacy are very clear, except for the effect of using typical values of the FOG rate constants in the op erational equation. When the typical values are equal to the true values in the examined tissue, no error is introduced by the use of these values. How ever, since the true values of these rate constants cannot be known in advance, they will most proba bly be different from the typical values used in the operational equation, and errors are then intro duced in the estimated LCMRGlc. For normal vari ations, it has been shown (Phelps et aI., 1979; Huang et aI., 1980) that the use of a set of typical values does not cause large errors, provided the measurement of tissue radioactivities is made be tween 40 and 120 min after FDG injection. In pa thology (e.g., epileptic seizure, stroke) or stimu lated states, where LCMRGlc can be higher or lower than normal values by as much as a factor of 5 (Kuhl et aI., 1980a,b; Engel et aI., 1981; Hawkins et aI., 1981; Phelps et aI., 1981) , the values of the rate constants would be significantly different from the typical values generally used in the operational equation. The effect of these large discrepancies on the accuracy of the estimated LCMRGlc has not been investigated systematically.
The [18F]fluorodeoxyglucose (FDG) method
In the use of the FOG method, another frequent problem is that the tissue metabolic activity is not in steady state, i.e., tissue LCMRGlc changes be tween the time of FOG injection and the time of tomographic measurements. For example, epileptic seizure activity can occur for a relatively small por tion of the time period of the study (Kuhl et aI., 1980a; Engel et aI., 1981) . Also, in some stimulation studies (Phelps et aI., 1981) , it may not be possible to maintain a constant condition for the duration of the experiment, due to practical considerations. However, in the derivation of the operational equa tion of the FOG method, the tissue LCMRGlc is 1 For purposes of brevity, the term FOG transport rate con stants will be used to denote the constants for forward and re versed transport of FOG across the blood-brain barrier and for FOG phosphorylation and FOG-6-P dephosphorylation.
J Cereb Blood FloII' Metabol. Vol. I. No. 4. 1981 assumed to be in a steady state (Sokoloff et aI., 1977; Phelps et aI., 1979; Huang et aI., 1980) . Therefore, by ignoring the time variations in the non-steady state cases, the LCMRGlc value estimated directly from the operational equation will not represent the true value of the tissue LCMRGlc and the relation ship between the estimated value and the tissue value is not accurately known.
In this work, computer simulations are used to investigate the error sensitivity of the FOG method to large deviations in the rate constants and to time variations in the rate constants that are related to changes in LCMRGlc. With computer simulation, exact values of tissue LCMRGlc can be chosen and the 18F tissue concentration that corresponds to vari ous physiological conditions can be simulated eas ily. The LCMRGlc value estimated from the tissue 18F radioactivity can then be compared to the simu lated true LCMRGlc values to evaluate the mag nitude of error under different conditions. An ap proximation formula useful for estimating these er rors is also presented.
METHODS
A schematic illustration of the computer simula tions is shown in Fig. 1 . For a prespecified set of rate constants, the corresponding 18F tissue con centration is simulated as a function of time. The operational equation of the FOG method is then applied to the simulated tissue concentration data at selected scan times as if the radioactivity concen tration were actually measured with a PCT scanner. One of the following two functions is selected in each simulation to represent the time function of FOG concentration in plasma:
Ct(t) = 650 e-6 .7t + 146 e-o. 2 5t + 105 e-o.o 3 t + 21 e-o.oOO l t ,
C 2 (t) = 5181 e-2 .7t + 593 e-O• 23 t + 150 e-o.o 44 t
where t is time in minutes following FOG injection.
These two functions are the best exponential fit (with 4 components) to two real FOG concentration curves obtained from two normal subjects after an i.v. bolus injection of FDG. The term C 1 represents cases where plasma FOG concentration drops more slowly, while C 2 represents a faster drop in plasma FDG concentration.
The transport of FOG in tissue is described by the compartmental model shown in Fig. 2 . For a known plasma FOG curve and a set of prespecified rate constants (k' s), the total 18F tissue concentration at a time T after FOG injection is calculated as (Phelps et aI., 1979; Huang et aI. , 1980) .
CF is the plasma FOG curve, ® denotes the opera tion of convolution, and the k's are the rate con stants shown in Fig. 2 . After the tissue radioactivity concentration has been simulated, the operational equation of the FOG method is applied to give an estimated LCMRGlc. The operational equation has the following form (Phelps et aI. , 1979; Huang et aI. , 1980) :
where MRest denotes the LCMRGlc estimated by the operational equation, Cp is the plasma glucose concentration, and the LC is a lumped constant.
Values of Cp and LC are kept constant in the simu lation studies with Cp = 90 mg/l00 ml and LC = 0.42 (Phelps et aI., 1979; Huang et aI. , 1980) . The values of the rate constants used in the operational equation are chosen to be the average values in gray matter in a group of normal subjects (Phelps et aI. , 1979; Huang et aI. , 1980) , i. e., kl = 0. 102 min-I, k2 = 0. 130 min -I, k3 = 0. 062 min -I, and k4 = 0.0068
According to the model of Fig. 2 In 2 klk" FDG transport rate constants" (min-I ) e Values in parentheses are the metabolic rates estimated by the operational equation (Eq. 4), when tissue is in that metabolic state.
(Tomographic scan time was 60 min; plasma FDG curve was C I of Eq. I.)
for a known set of rate constants can be calculated as (Phelps et aI., 1979; Huang et aI., 1980 )
The LCMRGlc value corresponding to the typical set of rate constants used in the operational equation is 7.06 mg/min/lOO g, referred to as the normal LCMRGlc value in tissue. By comparing the true LCMRGlc value (by Eq. 5) with the value estimated by the operational equation (Eq. 4), the errors due to the FDG method for a particular set of rate con stants can be calculated.
Twenty sets of rate constants shown in Table 1 were used in the study to simulate a wide range of different metabolic states. They correspond to LCMRGlc values from 0.2 to 5 times the normal values (i.e., LCMRGlc ranged from 1.41 to 35.3 mg/min/100 g), and there were 3 or 4 sets of rate constants for each LCMRGlc value. Different sets of rate constants for the same LCMRGlc were selected to represent variation of the distribution volume, k l /(k 2 + ka), and turnover time, In[2/(k2 + k3)], of the free FDG pool in tissue. The value of k 4 was not varied in this study because its value would not affect the true tissue LCMRGlc and also be-
cause its effect on the estimated LCMRGlc can be separated from the effects of the other rate con stants and has been evaluated previously (Huang et aI., 1980) .
In the simulation of non-steady-state cases, the tissue metabolic state is assumed to change from one state to the other in a negligibly short time, and the change is thus described mathematically by a step function. With a step function change, the 18F radioactivities at time T due to free FDG (CE) and phosphorylated FDG (CM) can be calculated as:
where and 0' 1 ' 0' 2 are as defined in Eq. 3, Ts is the time of the most recent metabolic change, and c'H(Ts), CE(Ts) are the radioactivities due to free FDG and phosphorylated FDG in tissue immediately before the change. The total 18F radioactivity in tissue is the sum of CM and CEo At any scan time T, the estimated LCMRGlc is obtained by applying the operational equation (Eq. 4) of the FDG method to the total 18F radioactivity in tissue.
The rate constants used to simulate various met abolic states are the same as those listed in Table 1 . The time of metabolic changes and the period in each metabolic state were varied systematically to examine their effect on the estimated LCMRGlc values. Figure 3 shows the estimated LCMRGlc (i. e., MRes ! by Eq. 4) as a function of scan time for four metabolic states that have one-half the normal LCMRGlc value (metabolic states 13 -17, Table O . At early scan times, the estimated LCMRGlc of the four different states differs greatly from one another and are all different from the true value. For scan times later than 50 min, the deviation among the four states becomes smaller. This reduction of de viation among different states is also seen in simu- lations with other LCMRGlc values and is consis tent with previous analytical results (Huang et al. , 1980) , which have shown that the estimated LCMRGlc by the FDG method (Eq. 4) is most sen sitive to the rate constants at early scan times but becomes less sensitive after 40 min. The present results also show that even at scan times later than 50 min, the estimated LCMRGlc has a systematic error (bias), depending on the magnitude of the dif ference between the true and normal LCMRGlc. Figure 4 shows the relationship between the true LCMRGlc and the estimated values (at a scan time of 60 min after FDG injection) for all the metabolic states listed in Table 1 . The deviation between the estimated and the true values is seen to be related to the difference between the true and normal LCMRGlc. The linear regression line (solid line) of the data crosses the line of identity (dashed line) near the normal LCMRGlc value but has a slope that is slightly but statistically significantly (p < 0.05) larger than 1, indicating an overestimation for LCMRGlc values larger than normal and underes timation for values lower than normal. The devia- 60, and 80 min, the error of the estimated LCMRGlc is smaller than or equal to 50, 33, 20, and 18%, respectively, of (MR -MR,,). Figure 5 shows the simulated 18F radioactivity as a function of time in a simulation in which the tissue LCMRGlc has been increased three fold during the time interval between 30 and 40 min after FDG in jection. The tissue 18F concentration increased much faster during the intervention interval than with no intervention. As a result, the tissue radioactivity concentration in later times was higher than in a case without the intervention, and the es timated LCMRGlc would give a value higher than normal, though not as high as if there had been a continuous intervention. Intervention started before FOG injection and stayed constant during intervention interval, the length of which is indicated on the abscissa. The tissue LCMRGlc returned to normal (i.e., 7.06 mg/min/100 g) afterward.
RESULTS
Radioactivity was measured at 60 min for the estimation of LCMRGlc. For results in this figure, the tissue LCMRGlc during intervention was 5 times normal value (i.e., 35.3 mg/ min/100 g). The three sets of data points correspond to states 10 (0), 11 (&) and 12 (e) in Table 1 . The solid curve in figure was generated from the plasma FOG curve CF according to Eq. 8 in the text. Curve C 2 of Eq. 2 was used for CF in this figure. and 7. In Fig. 6 which was at 60 min for the data in this figure. The abscissa is the time of return to the normal state. The intervention states corresponding to the three groups of data were the three different states (states 10-12 of Table 1 ) that had LCMRGlc 5 times the normal value. In Fig. 7 , the length of the interven tion was kept constant 00 min), but the starting time was varied (abscissa of the figure) . The solid curves in Figs. 6 and 7 were calculated according to the following equation
where MRp denotes the LCMRGlc value predicted by Eq. 8, WT = W(t"t2)IW(0,Tsc) and W (a, b) = fgcp(t) dt is the integral of the plasma FOG curve from time a to b, MRiot is the tissue LCMRGlc dur ing the intervention interval, MRn is the tissue's normal LCMRGlc (i.e., without intervention), t" t2 are the starting and ending times of intervention, and Tsc is the scan time. A close correspondence between MRp and MRest was seen for all interven tion intervals. Although data shown in Figs. 6 and 7 were for interventions with LCMRGlc 5 times the normal value and for a scan time at 60 min, results for intervention levels at 3, 2, 0.5, and 0.2 times normal LCMRGlc and for scan times at 30, 45, and 80 min were also obtained, and similar corre spondence between MRp and MRest were found. This shows that the estimated LCMRGlc can be predicted from the plasma FOG concentration curve, the intervention interval, and the interven tion LCMRGlc level. In other words, the estimated LCMRGlc value is approximately equal to the weighted average of the LCMRGlc between the FOG injection time and the scan time, with the weightings proportional to the areas under the plasma FOG curve of the corresponding intervals. This observation was found to be true irrespective of whether the plasma curve C, or curve C 2 was used in the simulation as long as the corresponding one was used in Eq. 8. Values of WT for various intervention intervals are shown in Table 2 for plasma curves C, and C 2.
DISCUSSION
In this work, the method of computer simulation was used primarily because there is no other simple and independent method for measuring the true LCMRGlc with which results from the FOG method can be directly compared. With computer simula tion, the true value of LCMRGlc is known exactly in advance, and the amount of error due to the op erational equation of the FDG method can be iso lated from other influencing factors. In addition, many conditions can be simulated easily, and more cases can be examined with computer simulation than with in vivo experiments. On the other hand, the results from computer simulation studies are useful only if the simulation has correctly repre sented the in vivo physiological conditions. For example, in the computer simulation of this work, the transport of FDG in brain tissue is assumed to be describable by the compartmental model of Fig.  2 . If this assumption is not true, the results from the simulation will have limited validity. The com partmental model of Fig. 2 , upon which the opera tional equation of the FDG method is based, has been developed according to known physiological and biochemical information (Bidder, 1968; Bachelard, 1971; Bessel et aI., 1972; Sokoloff et aI., 1977; Gallagher et aI., 1978) , and the validity of the model has been demonstrated previously by the time response of FDG uptake in tissue after an i. v. bolus injection (Phelps et aI., 1979; Huang et aI., 1980) . If the model of Fig. 2 is not valid, the results by the FDG method would also become question able. Hawkins et ai. (1981) applied the FDG method to ischemic regions in stroke patients and examined the accuracy of the method in these cases of mildly to severely reduced LCMRGlc. In their study, the control value of LCMRGlc was obtained by using the time activity information of FDG uptake in tis sue to estimate the transport rate constants in local tissue regions and then from these rate constants to calculate the LCMRGlc values (i.e., by Eq. 5) (Phelps et aI., 1979; Huang et aI., 1980) . They found that in a group of patients with severe ischemia (LCMRGlc by Eq. 5 equal to 1.79 ± 0.13 mg/min/ 100 g), the LCMRGlc value estimated by the opera tional equation (i.e., Eq. 4 with typical rate con stants of normal subjects) was 0.90 mg/min/IOO ga t a scan time of 60 min. The amount of underestima tion by the operational equation in these patients was 0.89 mg/min/IOO g, which was about 17% of the difference between the true and normal LCMRGlc (i.e., -0.89 = 0.17 (1.79 -7.06». Their result is quite compatible with the findings of the present study, providing support for the validity of the computer simulation approach used in this work.
The set of rate constants for a specific value of the LCMRGlc is not unique. The values in Table I were extrapolated from values measured in normal subjects (Phelps et aI., 1979; Huang et aI., 1980) and were somewhat arbitrary. They were selected to represent a wide range of variations in the values of k l /(k2 + k3) and (k2 + k3), which are related respec tively to the distribution volume and turnover rate of the free FDG pool in tissue. It was realized that some of these rate constants may not be realistic, but it was hoped that the extent of variation repre sented by these sets of rate constants would be larger than most variations encountered in patho logical or stimulated states and that the estimated LCMRGlc values in real tissues would be within the range of values obtained in the simulation study. In other words, the simulation results are expected to indicate the error ranges in realistic conditions de spite the somewhat arbitrary extrapolation of the rate constants from the normal measured values to those in altered states of metabolism.
The results of Fig. 4 show that the operational equation (Eq. 4) is likely to overestimate LCMRGlc if its value is higher than MRn and would underesti mate LCMRGlc if its value is below MRn. This over/underestimation tendency can be better under stood by considering the way MRes! is calculated by the operational equation. As shown in Fig. 1 , the equation uses the plasma FDG curve CF and the typical rate constants to estimate first the concen tration of free FDG (C E) and FDG-6-P (CM) in tis sue. These estimates (CE and CM) and the measured radioactivity concentration in tissue (Ci) are then used to form the factor, (C; -CE)/CM, that is mul tiplied by normal LCMRGlc, MR", to give MRes! (i.e., MRes! = MRn(Ci -CE)/C,,,,J (Phelps et aI., 1979; Huang et aI., 1980) . For LCMRGlc in the normal range, the typical rate constants in the oper ational equation could cause either an over-or an underestimation of CE• Usually, however, when CE is larger than true C E, C M is smaller than CM and vice versa. In other words, both the numerator (Ci -CE) and the denominator (CM) of the factor are affected in the same direction. And this accounts for the insensitivity of the operational equation to the rate constants in cases of normal LCMRGlc.
However, for LCMRGlc differing greatly from MR, ,, the factor (Ci -(;E) /(;M needs to be pro portional to the ratio LCMRGlc/MRn, to give correct estimates. Since MRn and C,,,, are unchanged (be cause the same k's are used), the difference (C; -CE), which is an estimate of FDG-6-P in tissue (i.e., CM), needs to be proportional to LCMRGlc. If tis sue C E is smaller (or larger) than C E, the term (CiCp;) will be smaller (or larger) than what it should be and MRes! will tend to under-(or over-) estimate LCMRGlc. In fact, as shown in Fig. 8 , left panel, the estimation error (I1MR = MRes! -MR) is strongly correlated with the value of ktfCk2 + k3), which is related directly to the distribution volume of free FDG (CE) in tissue. Although for a given value of k/(k 2 + k3), t:.MR is also correlated with LCMRGlc (Fig. 8, right panel) , the over/under estimation result of Fig. 4 is probably mainly due to the increase/decrease of the factor kl/(k 2 + k3), resulting from the choice of the rate constants in high/low metabolic states of Table 1 . Usually, an increase/decrease in LCMRGlc is accompanied by a parallel change in both the rates of phosphorylation and membrane transport of glucose (Siesjo, 1978; Hawkins et ai. , 1981) . Thus, the choice of the rate constants in Table 1 is not unreasonable. However, in cases where LCMRGlc and CE change in oppo· site directions, the association of over/underesti mation with high/low LCMRGlc may not apply. Also, the estimation error is strongly dependent on the plasma FDG concentration curve CF and the tomographic scan time. Therefore, the results of over/underestimation should be used only as a gen eral guideline and will need to be verified for each particular case.
The percentage number used in the formula for predicting the range of over/underestimation may seem small (e. g. , 20% of the difference between the actual and normal LCMRGlc for measurements at a scan time of 60 min), but relative to the actual tissue LCMRGlc, the estimation error will constitute a much larger percentage for extremely low LCMRGlc. For these cases, if one wants to use the op erational equation (Eq. 4), it is better to choose a set of rate constants that approximately correspond to the low LCMRGlc value being measured (Haw kins et ai. , 1981) . If the range of tissue LCMRGlc is not predictable in advance, a better estimate can also be obtained by iteratively adjusting the set of rate constants to match the MRest calculated in a previous iteration step. More accurate results, of course, can also be obtained by measuring the tis sue radioactivity (Ci) as a function of time. From this dynamic information, the rate constants of each local region can be estimated explicitly and Eq. 5 can be used to give more accurate values of LCMRGlc (Phelps et ai. , 1979; Huang et ai. , 1980; Hawkins et ai. , 1981) . However, the longer patient study time, the limitations imposed on the number of sections that can be studied, and the larger amount of data processing that are required with this approach make it rather inconvenient to be used for routine studies.
In the non-steady-state cases, the estimated LCMRGlc was found to be close to the weighted average value calculated by Eq. 8. A qualitative ex planation for the close correspondence is that the compartmental model of FDG (Fig. 2) is mathe matically a linear system and the plasma FDG curve is an input function to the system. For the case of small k4' the amount of 18F accumulated in tissue is approximately proportional to the integral of the input function, with a mUltiplication factor related to the transport rate constants. Because of the linearity of the system, the input function can be separated into a few segments and the accumulated tissue 18F can be considered as a sum of the contri butions due to each separate segment of the input function. In the non-steady-state case of variable rate constants, the multiplication factor for each segment is different, and thus the total amount of [8F that is approximately proportional to the esti mated LCMRGlc value at late scan times can be described by the form of Eq. 8. By rearranging terms in Eq. 8, the LCMRGlc value during intervention can be expressed in terms of the estimated LCMRGlc value as:
where CF = lIWT, and WT is defined in Eq. 8 and its values for various intervention intervals are listed in Table 2 . Thus, theoretically, the true LCMRGlc value during intervention can be calcu lated from the estimated LCMRGlc value, if the time interval of intervention is known. However, as shown in Table 2 , the values of CF for short inter ventions are quite large, and any discrepancy be tween the estimated LCMRGlc and the weighted average value by Eq. 8 will be amplified and could cause large error in predicting the LCMRGlc of in tervention. Thus, Eq. 9 is expected to be useful only in providing a general range rather than an accurate value of LCMRGlc during intervention. Equation 9 is also important for predicting the effect or for properly designing the experimental protocol in studies where altered states of LCMRGlc can be maintained for only a fraction of the total study time.
In the present study, only three of the four FDG transport rate constants were altered in various metabolic states. The fourth rate constant, k4' which is the rate of dephosphorylation of FDG-6-P, has not been varied because LCMRGlc is not di rectly related to it (Eq. 5), and the effect on MRest due to errors in k4 can be considered separately. The effect due to errors in k4 has been examined previously (Huang et aI., 1980) . Variation of k4 in tissue can result in either an overestimation or an underestimation of true tissue LCMRGlc, depend ing on whether the k4 value in tissue is smaller or larger than the value assumed in the operational equation. Also, although the effect of k4 is normally small in the time from zero to 40 min, it becomes more significant as the time between FDG injection and PCT scanning increases (Phelps et aI., 1979; Huang et aI., 1980) . Thus, the effect due to varia tions in k4 could either increase or decrease the er rors examined in the present study and should be taken into consideration when estimating the total error in MRest. If dephosphorylation were to be ac celerated relative to phosphorylation in pathology,
the error due to the use of the average normal value of k4 would be increased (Phelps et aI., 1979; Huang et aI., 1980; Hawkins et aI., 1981) .
In addition to the rate constants, there are two other values used in the operational equation, i.e., the lumped constant, LC, and the plasma glucose concentration, Cp • Since LCMRGlc calculated by the operational equation is directly proportional to Cp and inversely proportional to LC, percentage er rors in Cp and LC will be directly reflected in the calculated LCMRGlc values. The constancy of LC has been investigated by Hawkins et al. (1981) . They have found that the LC value for cerebral tis sue does not vary much, even under severely is chemic conditions. However, LC could vary in cases where glucose utilization is limited by membrane transport (e.g., in severe hypoglycemia). In the pres ent work, the values of Cp and LC were assumed to be equal to 90 mg % and 0.42, respectively (Phelps et aI., 1979; Huang et aI., 1980) , and were held con stant for all metabolic states. In cases where these values deviate greatly from normal, the results re ported in this work can only be applied to the factor k[k3/(kz + k3) instead of to LCMRGlc. For example, in a case of extremely high or low Cp , if the factor k[k3/(kz + k3) remains in the normal range, the LCMRGlc value estimated by the FDG method will be quite accurate (within ± 10% SD of true value) and the systematic over-or underestimation is not expected, although the tissue LCMRGlc in this case could be significantly higher or lower than the nor mal value. On the other hand, if tissue LCMRGlc is normal but the values of Cp and the factor k [k3/(kz + k3) deviate in opposite directions from their normal values, the LCMRGlc value estimated by the FDG method is expected to have systematic errors, the size of which will depend on the magnitude of the deviation of the factor klk3/(kz + k3) from normal.
In the non-steady-state case, if Cp varies as a function of time but the factor klk3/(kz + k3) remains constant at its normal value, Eq. 8 is expected to remain applicable in predicting MRest. because ac cording to Eq. 5, Cp and the factor k1k3/(k2 + k3) affect tissue LCMRGlc value in the same way. However, if the factor klk3/(kz + k3) differs greatly from the normal values, the over-or underestima tion discussed in the preceding paragraph should also be considered.
In the simulation, two typical time activity curves of plasma FDG concentration have been used. The curves were obtained from normal subjects after an i.v. bolus injection of FDG. For studies that have other FDG injection schedules (e.g., prolonged in jections to reduce the high sensitivity to conditions in the initial times), the time activity curve of plasma FDG could be much different. This will af fect the weighting and correction factors for es timating LCMRGIc in the non-steady-state cases, hut the formula of Eq. 8 is still expected to be valid. In the steady state case of large LCMRGIc devia tions, the plasma FDG activity curve is not ex pected to affect the direction of over-or underesti mation, although the range of the systematic esti mation error could be related to the shape of the curve.
The normal value of LCMRGIc and the typical rate constants used in the present work corre sponded to values in gray matter of human brain. In a few simulations where values corresponded to white matter were used, similar results were ob tained.
Although the step function used to simulate LCMRGIc changes in non-steady-state cases is not very realistic, it is a simple approximation. Since hoth the FDG time activity curve and the FDG re sponse in tissue have time constants on the order of at least a few minutes, no unrealistic changes of tissue 18F appear in the simulation. Slower changes in LCMRGIc can also be approximated by a series of step functions. The formulas for calculating the weightings and correction factors are expected to remain applicable.
The conditions that were simulated in this work are far from representing all possible situations that one would encounter in various research studies. Also, in addition to the inaccuracies of the rate con stants, there are other potential sources of errors, such as uncertainties in the measurements of tissue radioactivity and plasma glucose level, in the FDG method. The results reported, however, are in tended to give some guidance for interpreting or correcting the LCMRGIc values obtained by the FDG method. The results should provide a better understanding of the strength and limitations of the FDG method that will be useful for designing ex perimental protocols for the meas urement of LCMRGIc with the FDG method. In using these results, one should also keep in mind the assump tions made in the simulations. If the assumptions are not valid in certain particular cases, extrapola tion of the results must be done with care.
